Nicotinic Antagonists
Nicotinic Antagonist is a pharmacological agent that selectively inhibits nicotinic acetylcholine receptors, thereby blocking neurotransmission mediated by acetylcholine at nicotinic synapses in the autonomic nervous system and neuromuscular junction.
1.5K
Publications
82.6K
Citations
4.9K
Authors
1.1K
Institutions
Publications per year
2017–2026
91
Variants
Nicotinic Cholinergic AntagonistsNicotinic Receptor Antagonists
1.5K
Cholinergic modulation of microglial activation by α7 nicotinic receptors
R. Douglas Shytle, Takashi Mori, Kirk Townsend et al. · Journal of Neurochemistry · 2004 · 525 citations · Full text
1–5 of 1.5K
4.9K
30
h-index
25
h-index
24
h-index
22
h-index
Virginia Commonwealth University Medical Center, United States
20 publications · 1.6K citations
16
h-index
1–5 of 4.9K
1.1K
University of Utah
Salt Lake City, United States
33 h-index
121 publications
8K citations
University of Kentucky
Lexington, United States
31 h-index
206 publications
7.4K citations

Karolinska Institutet
Stockholm, Sweden
26 h-index
85 publications
9K citations
Duke Medical Center
Durham, United States
26 h-index
107 publications
5.8K citations
Duke University Hospital
Durham, United States
22 h-index
78 publications
4.5K citations
Duke University
Durham, United States
21 h-index
54 publications
3.1K citations

Virginia Commonwealth University Medical Center
Richmond, United States
19 h-index
80 publications
4.4K citations
National Institutes of Health
Bethesda, United States
19 h-index
77 publications
5K citations
1–8 of 1.1K
94 publications · 6K citations
45
h-index
60 publications · 6.5K citations
45
h-index
60 publications · 4K citations
38
h-index
BJP · 62 publications · 2.8K citations
34
h-index
JNC · 44 publications · 4.5K citations
33
h-index
1–5